# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Bluejay Diagnostics, Inc. (NASDAQ:BJDX) ("Bluejay" or the "Company"), a medical technology company developing r...
Bluejay Diagnostics (NASDAQ:BJDX) reported quarterly losses of $(1.78) per share which missed the analyst consensus estimate of...